Synergy between azoles and 1,4-dihydropyridine derivative as an option to control fungal infections

@article{Jekov2017SynergyBA,
  title={Synergy between azoles and 1,4-dihydropyridine derivative as an option to control fungal infections},
  author={Zuzana Je{\vz}{\'i}kov{\'a} and Tom{\'a}{\vs} Pag{\'a}{\vc} and Barbora Pfeiferov{\'a} and H Bujd{\'a}kov{\'a} and Stanislava Di{\vz}ov{\'a} and Iva Jan{\vc}{\'i}kov{\'a} and Dana G{\'a}{\vs}kov{\'a} and Petra Olejn{\'i}kov{\'a}},
  journal={Antonie van Leeuwenhoek},
  year={2017},
  volume={110},
  pages={1219-1226}
}
With emerging fungal infections and developing resistance, there is a need for understanding the mechanisms of resistance as well as its clinical impact while planning the treatment strategies. Several approaches could be taken to overcome the problems arising from the management of fungal diseases. Besides the discovery of novel effective agents, one realistic alternative is to enhance the activity of existing agents. This strategy could be achieved by combining existing antifungal agents with… CONTINUE READING
1
Twitter Mention

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.

Synergy Over Monotherapy

  • Current Microbiology
  • 2019
VIEW 8 EXCERPTS
CITES RESULTS & BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

A (2015) Detection of inhibitors of Candida albicans Cdr

J Szczepaniak, M Lukaszewicz, Krasowska
  • 2015
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Antifungal stewardship in invasive Candida infections.

  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2014
VIEW 1 EXCERPT

Hidden killers: human fungal infections.

  • Science translational medicine
  • 2012
VIEW 1 EXCERPT